Efficacy of clofibrate on severe neonatal jaundice associated with glucose-6-phosphate dehydrogenase deficiency (a randomized clinical trial)

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 39, Issue 3, 2008, Pages 557-561

  Zahedpasha, Yadollah ^a   Ahmadpour Kacho, Mousa ^a   Hajiahmadi, Mahmood ^a   Naderi, Salma ^a   Kamali, Abbas Ali ^a  

^a BABOL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 44949265333     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Agrawal R, Aggarwal R, Deorari AK, Paul VK. Jaundice in the newborn. Indian J Pediatr 2001; 68: 977-80.
2. Bourget P, Broise I, Quinquis-Desmaris V, Gabilan JC. Pharmacokinetics of clofibrate in jaundiced newborn infants at term. Arch Pediatr 1995; 2: 722-8.
3. Brun S, Carmona MC, Mampel T, et al. Activators of peroxisome proliferator-activated receptor-alpha induce the expression of the uncoupling protein-3 gene in skeletal muscle: a potential mechanism for the lipid intake-dependent activation of uncoupling protein-3 gene expression at birth. Diabetes 1999; 48: 1217-22.
4. Caballero NB, Hernandez PS, Rodriguez JBE, et al. Clofibrate effects associated with phototherapy on bilirubin concentration in newly-born babies. Rev Mex Pediatr 2001; 68: 176-80.
5. Dennery PA. Pharmacological interventions for the treatment of neonatal jaundice. Semin Neonatal 2002; 7: 111-9.
6. Gabilan JC. Pharmacologic treatment of neonatal jaundice. A new approach. Arch Pediatr 1998; 5: 1274-8.
7. Hansen TW, Tommarello S. Effect of phenobarbital on bilirubin metabolism in rat brain. Biol Neonate 1998; 73: 106-11.
8. Iolascon A, Faienza MF, Perrotta S, Meloni GF, Ruggiu G, Del Giudice EM. Gilbert's syndrome and jaundice in glucose-6-phosphate dehydrogenase deficient neonates. Haematologica 1999; 84: 99-102.
9. Kappas A, Drummond GS, Valaes T. A single dose of Sn-mesoporphyrin prevents development of severe hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns. Pediatrics 2001; 108: 25-30.
10. Kutz K, Kandler H, Gugler R, Fevery J. Effect of Clofibrate on the metabolism of bilirubin, bromosulphophthalein and indocyanine green and on the biliary lipid composition in Gilbert's syndrome. Clin Sci (Lond) 1984; 66: 389-97.
11. Lindenbaum A, Hernandorena X, Vial M, et al. Clofibrate for the treatment of hyperbilirubinemia in neonates born at term: a double blind controlled study. Arch Fr Pediatr 1981; 38 (suppl 1): 867-73.
12. Lindenbaum A, Delaporte B, Benattar C, et al. Preventive treatment of jaundice in premature newborn infants with clofibrate. Double-blind controlled therapeutic trial. Arch Fr Pediatr 1985; 42: 759-
13. Mohammadzadeh A, Farhat ASh, Iranpour R. Effect of clofibrate in jaundiced term newoorns, Indian J Pediatr 2005; 72: 123-6.
14. Murki S, Dutta S, Narang A, Sarkar U, Garewal G. A randomized, triple-blind, placebo-controlled trial of prophylactic oral Phenobarbital to reduce the need for phototherapy in G6PD-deficient neonates, J Perinatol 2005; 25: 325-30.
15. Rubaltelli FF. Current drug treatment options in neonatal hyperbilirubinaemia and the prevention of kernicterus. Drugs 1998; 56: 23-30.
16. Steiner A, Weisser B, Vetter W. A comparative review of the adverse effects of treatments for hyperlipidaemia. Drug Saf 1991; 6: 118-30.
17. Valaes T, Drummond GS, Kappas A. Control of hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns using an inhibitor of bilirubin production, Sn-mesoporphyrin. Pediatrics 1999; 103: 536-7.
18. Weisz B, Belson A, Milbauer B, Reif S. Complications of exchange transfusion in term and preterm newborns. Harefuah 1996; 130: 170-3.
19. World Health Organization. Working group, World map of G6PD deficiency. Geneva: WHO, 1989; 67: 601.
20. Zahedpasha Y, Ahmadpour-Kacho M, Hajiahmadi M, Naderi S. Effect of clofibrate in jaundiced full-term infants: a randomized clinical trial. Arch Iran Med 2007; 10: 349-53.